SCHEMBL6170777

SCHEMBL6170777

CC(c1ccncc1-c1cccc(Cl)c1)C1NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.38
GRIN2B Q13224 1/20 0.35
FNTA P49354 1/20 0.35
FNTB P49356 1/20 0.35
PGGT1B P53609 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
DGAT2 Q96PD7 3/20 0.34
ABL1 P00519 4/20 0.33
CXCR3 P49682 1/20 0.33
NPBWR1 P48145 1/20 0.33
MCHR1 Q99705 1/20 0.33
POLB P06746 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
SLC5A1 P13866 3/20 0.33
CHRM5 P08912 1/20 0.33
DYRK1A Q13627 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172100 0.90 LMNA (0.38) LMNAFNTAFNTBPGGT1BABL1
SCHEMBL6173731 0.87 KDM4E (0.35) LMNAKDM4EALDH1A1SMN1; SMN2
SCHEMBL6172120 0.86 KDM4E (0.35) LMNAKDM4EALDH1A1SMN1; SMN2
SCHEMBL6174750 0.85 LMNA (0.39) LMNACXCR3NPBWR1MCHR1POLB
SCHEMBL6173698 0.84 LMNA (0.42) LMNACXCR3NPBWR1MCHR1POLB
SCHEMBL6175153 0.82 LIPE (0.43) ABL1POLB
SCHEMBL6174788 0.81 LMNA (0.38) LMNAGRIN2BABL1NPBWR1MCHR1
SCHEMBL6173186 0.79 LMNA (0.40) LMNACXCR3NPBWR1MCHR1POLB
SCHEMBL6172442 0.78 LMNA (0.40) LMNACXCR3NPBWR1MCHR1POLB
SCHEMBL6170501 0.78 LMNA (0.42) LMNACXCR3POLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed